247 related articles for article (PubMed ID: 28084320)
1. Structural basis for the recognition and degradation of host TRIM proteins by Salmonella effector SopA.
Fiskin E; Bhogaraju S; Herhaus L; Kalayil S; Hahn M; Dikic I
Nat Commun; 2017 Jan; 8():14004. PubMed ID: 28084320
[TBL] [Abstract][Full Text] [Related]
2. The Salmonella Effector Protein SopA Modulates Innate Immune Responses by Targeting TRIM E3 Ligase Family Members.
Kamanova J; Sun H; Lara-Tejero M; Galán JE
PLoS Pathog; 2016 Apr; 12(4):e1005552. PubMed ID: 27058235
[TBL] [Abstract][Full Text] [Related]
3. The inflammation-associated Salmonella SopA is a HECT-like E3 ubiquitin ligase.
Zhang Y; Higashide WM; McCormick BA; Chen J; Zhou D
Mol Microbiol; 2006 Nov; 62(3):786-93. PubMed ID: 17076670
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of SopA, a Salmonella effector protein mimicking a eukaryotic ubiquitin ligase.
Diao J; Zhang Y; Huibregtse JM; Zhou D; Chen J
Nat Struct Mol Biol; 2008 Jan; 15(1):65-70. PubMed ID: 18066077
[TBL] [Abstract][Full Text] [Related]
5. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
7. Recognition and ubiquitination of Salmonella type III effector SopA by a ubiquitin E3 ligase, HsRMA1.
Zhang Y; Higashide W; Dai S; Sherman DM; Zhou D
J Biol Chem; 2005 Nov; 280(46):38682-8. PubMed ID: 16176924
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of two bacterial HECT-like E3 ligases in complex with a human E2 reveal atomic details of pathogen-host interactions.
Lin DY; Diao J; Chen J
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):1925-30. PubMed ID: 22308380
[TBL] [Abstract][Full Text] [Related]
9. The E3 ligase TRIM56 is a host restriction factor of Zika virus and depends on its RNA-binding activity but not miRNA regulation, for antiviral function.
Yang D; Li NL; Wei D; Liu B; Guo F; Elbahesh H; Zhang Y; Zhou Z; Chen GY; Li K
PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007537. PubMed ID: 31251739
[TBL] [Abstract][Full Text] [Related]
10. TRIM E3 Ubiquitin Ligases in Rare Genetic Disorders.
Meroni G
Adv Exp Med Biol; 2020; 1233():311-325. PubMed ID: 32274764
[TBL] [Abstract][Full Text] [Related]
11. Structure and catalytic activation of the TRIM23 RING E3 ubiquitin ligase.
Dawidziak DM; Sanchez JG; Wagner JM; Ganser-Pornillos BK; Pornillos O
Proteins; 2017 Oct; 85(10):1957-1961. PubMed ID: 28681414
[TBL] [Abstract][Full Text] [Related]
12. Overlapping and distinct molecular determinants dictating the antiviral activities of TRIM56 against flaviviruses and coronavirus.
Liu B; Li NL; Wang J; Shi PY; Wang T; Miller MA; Li K
J Virol; 2014 Dec; 88(23):13821-35. PubMed ID: 25253338
[TBL] [Abstract][Full Text] [Related]
13. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
14. Identification of TRAF6 as a ubiquitin ligase engaged in the ubiquitination of SopB, a virulence effector protein secreted by Salmonella typhimurium.
Ruan HH; Li Y; Zhang XX; Liu Q; Ren H; Zhang KS; Zhao H
Biochem Biophys Res Commun; 2014 Apr; 447(1):172-7. PubMed ID: 24704445
[TBL] [Abstract][Full Text] [Related]
15. SopA inactivation or reduced expression is selected in intracellular Salmonella and contributes to systemic Salmonella infection.
Ma S; Liu X; Ma S; Jiang L
Res Microbiol; 2021 Mar; 172(2):103795. PubMed ID: 33347947
[TBL] [Abstract][Full Text] [Related]
16. TRIM65 E3 ligase targets VCAM-1 degradation to limit LPS-induced lung inflammation.
Li Y; Huang X; Guo F; Lei T; Li S; Monaghan-Nichols P; Jiang Z; Xin HB; Fu M
J Mol Cell Biol; 2020 Apr; 12(3):190-201. PubMed ID: 31310649
[TBL] [Abstract][Full Text] [Related]
17. The Functions of TRIM56 in Antiviral Innate Immunity and Tumorigenesis.
Fu L; Zhou X; Jiao Q; Chen X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902478
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H.
Lazzari E; El-Halawany MS; De March M; Valentino F; Cantatore F; Migliore C; Onesti S; Meroni G
Cells; 2019 Mar; 8(3):. PubMed ID: 30884854
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants of TRIM protein function.
Esposito D; Koliopoulos MG; Rittinger K
Biochem Soc Trans; 2017 Feb; 45(1):183-191. PubMed ID: 28202672
[TBL] [Abstract][Full Text] [Related]
20. Impaired Antiviral Responses to Extracellular Double-Stranded RNA and Cytosolic DNA, but Not to Interferon-α Stimulation, in TRIM56-Deficient Cells.
Wang D; Wang R; Li K
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
